Wild-Type Transthyretin Amyloid Cardiomyopathy: A Missed Cause of Heart Failure with Preserved Ejection Fraction with Evolving Treatment Implications

Circulation

Volumn 133, Issue 3, 2016, Pages 245-247

  Liu, Peter P ^a   Smyth, David ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

amyloid; cardiomyopathy; Editorials; heart failure; treatment outcome

Indexed keywords

AGING; AMYLOID NEUROPATHIES, FAMILIAL; FEMALE; HEART FAILURE; HUMAN; MALE; PATHOLOGY;

AGING; AMYLOID NEUROPATHIES, FAMILIAL; FEMALE; HEART FAILURE; HUMANS; MALE;

EID: 84955629741     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.020351     Document Type: Review

References (11)

1. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP, Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006 355 260 269. doi: 10.1056/NEJMoa051530
2. Ruberg FL, Berk JL, Transthyretin (TTR) cardiac amyloidosis. Circulation 2012 126 1286 1300. doi: 10.1161/CIRCULATIONAHA.111.078915
3. Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, Berk JL, Seldin DC, Heart failure resulting from age-related cardiac amyloid disease associated with wild-Type transthyretin: a prospective, observational cohort study. Circulation 2016 133 282 290. doi: 10.1161/CIRCULATIONAHA.115.018852
4. Cornwell GG 3rd, Murdoch WL, Kyle RA, Westermark P, Pitkänen P, Frequency and distribution of senile cardiovascular amyloid: a clinicopathologic correlation. Am J Med 1983 75 618 623
5. Tanskanen M, Peuralinna T, Polvikoski T, Notkola IL, Sulkava R, Hardy J, Singleton A, Kiuru-Enari S, Paetau A, Tienari PJ, Myllykangas L, Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med 2008 40 232 239. doi: 10.1080/07853890701842988
6. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA, SENIORS Investigators Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005 26 215 225. doi: 10.1093/eurheartj/ehi115
7. Pinney JH, Whelan CJ, Petrie A, Dungu J, Banypersad SM, Sattianayagam P, Wechalekar A, Gibbs SD, Venner CP, Wassef N, McCarthy CA, Gilbertson JA, Rowczenio D, Hawkins PN, Gillmore JD, Lachmann HJ, Senile systemic amyloidosis: clinical features at presentation and outcome. J Am Heart Assoc 2013 2 e000098. doi: 10.1161/JAHA.113.000098
8. Kristen AV, Haufe S, Schonland SO, Hegenbart U, Schnabel PA, Röcken C, Hardt S, Lohse P, Ho AD, Haberkorn U, Dengler TJ, Altland K, Katus HA, Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis. Int J Cardiol 2013 164 179 184. doi: 10.1016/j.ijcard.2011.06.123
9. Hawkins PN, Ando Y, Dispenzeri A, Gonzalez-Duarte A, Adams D, Suhr OB, Evolving landscape in the management of transthyretin amyloidosis [published online ahead of print November 27, 2015]. Ann Med. doi: 10.3109/07853890.2015.1068949. http://www.tandfonline.com/doi/full/10.3109/07853890.2015.1068949#.Vmsukr8YF2A. Accessed December 11, 2015
10. Coelho T, Adams D, Silva A, Lozeron P, Hawkins PN, Mant T, Perez J, Chiesa J, Warrington S, Tranter E, Munisamy M, Falzone R, Harrop J, Cehelsky J, Bettencourt BR, Geissler M, Butler JS, Sehgal A, Meyers RE, Chen Q, Borland T, Hutabarat RM, Clausen VA, Alvarez R, Fitzgerald K, Gamba-Vitalo C, Nochur SV, Vaishnaw AK, Sah DW, Gollob JA, Suhr OB, Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med 2013 369 819 829. doi: 10.1056/NEJMoa1208760
11. Greene MJ, Klimtchuk ES, Seldin DC, Berk JL, Connors LH, Cooperative stabilization of transthyretin by clusterin and diflunisal. Biochemistry 2015 54 268 278. doi: 10.1021/bi5011249